高タンパク質の食事と代謝機能不全に関連した脂肪性肝疾患:肝臓の健康における両刃の剣
Hong-Yuan Yin1, Qian-Hui You2, Wei-Jie Zhang3
1Institute of Digestive Diseases, Longhua Hospital, China-Canada Center of Research for Digestive Diseases, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China.
World journal of gastroenterology
|February 16, 2026
まとめ
高タンパク質の食事 (HPD) は,代謝機能不全に関連した脂肪性肝疾患 (MASLD) に混合的な効果を示しています. 植物性たんぱく質は,MASLD管理のためのHPDに個別化されたアプローチを提案し,利点を提供しています.
科学分野:
- ヘパトロジーと栄養科学
背景:
- 代謝機能障害に関連したステアトス肝疾患 (MASLD) は,代謝障害に関連した広範な慢性肝疾患です.
- 高タンパク質ダイエット (HPD) は,代謝健康のためにますます研究されていますが,MASLDにおけるその役割は議論されています.
研究 の 目的:
- MASLDに対するHPDの影響を体系的に検討する.
- MASLDにおける肝臓の代謝,炎症,腸内微生物群に関するHPDのメカニズムを調べる.
- MASLDに対するHPDの臨床効果を評価する.
主な方法:
- 疫学研究,臨床試験,基礎研究を体系的にレビューする.
- 肝臓の代謝,炎症反応,腸内微生物群を含むメカニズムを分析する.
- 臨床効果とタンパク質源への影響の評価.
主要な成果:
- HPDは,タンパク質の源と摂取量によって影響を受け,MASLDに二重な効果を発揮します.
- 植物性タンパク質は,MASLD患者の代謝上の利点を示しています.
- 特定のタンパク質の供給源と消費パターンは,MASLDの評価に不可欠です.
結論:
- MASLDの患者は,植物性タンパク質を優先し,適度な動物性タンパク質の摂取を推奨する.
- 将来の研究は,HPDメカニズムとパーソナライズされた栄養戦略に焦点を当てるべきです.
- マルチオミックスのデータを統合することで,MASLDの予防と治療のための正確な食事アルゴリズムを可能にすることができます.
関連する概念動画
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
212
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
212
Overview of Lipid Metabolism
5.7K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
5.7K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
257
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
257
Overview of Protein Metabolism
4.1K
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
4.1K
Liver Physiology
3.9K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
3.9K
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
234
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
234


